Healthy volunteers help test new tablet batches
NCT ID NCT07214922
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the body absorbs and processes different manufacturing batches of an experimental tablet called evobrutinib. Twenty-eight healthy adults took a single dose of each batch, and researchers measured drug levels in the blood and checked for side effects. The goal was to see if the batches work the same way in the body, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nuvisan GmbH
Neu-Ulm, 89231, Germany